These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 39330486)

  • 1. Impact of Phenylketonuria on the Serum Metabolome and Plasma Lipidome: A Study in Early-Treated Patients.
    Weerd JCV; Wegberg AMJV; Boer TS; Engelke UFH; Coene KLM; Wevers RA; Bakker SJL; Blaauw P; Groen J; Spronsen FJV; Heiner-Fokkema MR
    Metabolites; 2024 Aug; 14(9):. PubMed ID: 39330486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma metabolomic profile changes in females with phenylketonuria following a camp intervention.
    Schoen MS; Singh RH
    Am J Clin Nutr; 2022 Mar; 115(3):811-821. PubMed ID: 34864852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuria.
    van Wegberg AMJ; van der Weerd JC; Engelke UFH; Coene KLM; Jahja R; Bakker SJL; Huijbregts SCJ; Wevers RA; Heiner-Fokkema MR; van Spronsen FJ
    J Inherit Metab Dis; 2024 Jul; 47(4):624-635. PubMed ID: 38556470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Phospholipidomic Profile Differs between Children with Phenylketonuria and Healthy Children.
    Guerra IMS; Diogo L; Pinho M; Melo T; Domingues P; Domingues MR; Moreira ASP
    J Proteome Res; 2021 May; 20(5):2651-2661. PubMed ID: 33819046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylketonuria (PKU) Urinary Metabolomic Phenotype Is Defined by Genotype and Metabolite Imbalance: Results in 51 Early Treated Patients Using Ex Vivo
    Cannet C; Bayat A; Frauendienst-Egger G; Freisinger P; Spraul M; Himmelreich N; Kockaya M; Ahring K; Godejohann M; MacDonald A; Trefz F
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylalanine hydroxylase deficient phenylketonuria comparative metabolomics identifies energy pathway disruption and oxidative stress.
    Dobrowolski SF; Phua YL; Sudano C; Spridik K; Zinn PO; Wang Y; Bharathi S; Vockley J; Goetzman E
    Mol Genet Metab; 2021 Apr; ():. PubMed ID: 33846068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.
    Blasco H; Veyrat-Durebex C; Bertrand M; Patin F; Labarthe F; Henique H; Emond P; Andres CR; Antar C; Landon C; Nadal-Desbarats L; Maillot F
    JIMD Rep; 2017; 32():69-79. PubMed ID: 27300702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pah
    Lu LH; Xia ZX; Guo JL; Xiao LL; Zhang YJ
    CNS Neurosci Ther; 2020 Apr; 26(4):486-493. PubMed ID: 31471952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation.
    Cannet C; Pilotto A; Rocha JC; Schäfer H; Spraul M; Berg D; Nawroth P; Kasperk C; Gramer G; Haas D; Piel D; Kölker S; Hoffmann G; Freisinger P; Trefz F
    Orphanet J Rare Dis; 2020 Feb; 15(1):61. PubMed ID: 32106880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative metabolomics in the Pah
    Dobrowolski SF; Phua YL; Sudano C; Spridik K; Zinn PO; Wang Y; Bharathi S; Vockley J; Goetzman E
    Mol Genet Metab; 2022 May; 136(1):38-45. PubMed ID: 35367142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotyping in phenylketonuria reveals disease clustering independently of metabolic control.
    Moritz L; Klotz K; Grünert SC; Hannibal L; Spiekerkoetter U
    Mol Genet Metab; 2023 Mar; 138(3):107509. PubMed ID: 36791482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
    Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.
    Douglas TD; Jinnah HA; Bernhard D; Singh RH
    Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids and phenylketonuria: Current evidences pointed the need for lipidomics studies.
    Guerra IMS; Ferreira HB; Neves B; Melo T; Diogo LM; Domingues MR; Moreira ASP
    Arch Biochem Biophys; 2020 Jul; 688():108431. PubMed ID: 32461102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of dietary fatty acid restriction in patients with phenylketonuria.
    Mütze U; Beblo S; Kortz L; Matthies C; Koletzko B; Bruegel M; Rohde C; Thiery J; Kiess W; Ceglarek U
    PLoS One; 2012; 7(8):e43021. PubMed ID: 22912778
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.